On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

SIGA Technologies (SIGA) stock gains as Japan approves antiviral Tepoxx as a treatment for orthopoxviruses including mpox.

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, ...

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno Pharma Co., Ltd. engaged as exclusive distribu ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as ...

A 53-year-old Alabama woman became the third patient in the US to receive a kidney transplant from a genetically modified pig. A team of surgeons from NYU Langone Health operated. Maria Mulgrew was ...

SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses: New York Saturday, January 4, 2025, 12:00 Hrs [IST] SIGA Technologies, a commercial s ...

It was carried out in Argentina, Brazil, Japan, Mexico, Peru ... which found the drug was no better than placebo at mitigating mpox symptoms, as well as preventing serious outcomes including ...

8 - The Canadian Football League announces that the 2026 Grey Cup championship will be hosted by the Calgary Stampeders at ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

The health ministry has urged states to strengthen and review surveillance of Influenza Like Illness (ILI) and Severe Acute ...

while KM Biologics' LC16 vaccine is available in Japan and Emergent BioSolutions' ACAM2000 is under regulatory review for mpox in the US, according to GlobalData. "Procurement of vaccines to ...